Company Filing History:
Years Active: 2018-2025
Title: Zhulin Wang: Innovator in Immune Agonists
Introduction
Zhulin Wang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of immunology, particularly through his innovative work on immune agonists. With a total of 4 patents, his research focuses on enhancing immune responses and developing novel therapeutic agents.
Latest Patents
Zhulin Wang's latest patents include groundbreaking advancements in immune agonists. One of his notable inventions is a series of small molecular immune agonists of Toll-like receptors, which are designed to activate and amplify immune cells and lymphocytes. This application also outlines the potential use of these immune agonists in preparing immunomodulatory drugs, immune anti-tumor small molecule drugs, and immune anti-tumor macromolecular drugs. Another significant patent involves a series of homologous small molecule immune agonists and bifunctional immune targeting compounds. These compounds are created by coupling small molecule immune agonists to targeting drugs, enhancing the immune activation effects and anti-tumor capabilities of the targeting drugs.
Career Highlights
Zhulin Wang has worked with notable institutions such as Shenzhen University and Shenzhen Kangjuzheng Pharmaceutical Technology Co., Ltd. His work in these organizations has allowed him to further his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Zhulin Wang has collaborated with esteemed colleagues, including Guangyi Jin and Li Tang. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and advancements in the field of immunology.
Conclusion
Zhulin Wang's contributions to the field of immune agonists highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic approaches in immunology.